{"id":"https://openalex.org/W2361759378","doi":"https://doi.org/10.4268/cjcmm20121802","title":"Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring","display_name":"Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring","publication_year":2012,"publication_date":"2012-09-15","ids":{"openalex":"https://openalex.org/W2361759378","doi":"https://doi.org/10.4268/cjcmm20121802","mag":"2361759378","pmid":"https://pubmed.ncbi.nlm.nih.gov/23285908"},"language":"zh","primary_location":{"id":"doi:10.4268/cjcmm20121802","doi":"https://doi.org/10.4268/cjcmm20121802","is_oa":false,"landing_page_url":"https://doi.org/10.4268/cjcmm20121802","pdf_url":null,"source":{"id":"https://openalex.org/S2756327665","display_name":"China Journal of Chinese Materia Medica","issn_l":"1001-5302","issn":["1001-5302"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4320800687","host_organization_name":"Chinese Pharmaceutical Association","host_organization_lineage":["https://openalex.org/P4320800687"],"host_organization_lineage_names":["Chinese Pharmaceutical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"China Journal of Chinese Materia Medica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100709844","display_name":"Dan Wang","orcid":"https://orcid.org/0000-0001-9079-2360","observed_orcids":["https://orcid.org/0000-0001-9079-2360"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"WANG Dan","raw_affiliation_strings":["Center for Drug Evaluation, State Food and prug Administration, Beijing 100045, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Drug Evaluation, State Food and prug Administration, Beijing 100045, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5100709844"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.18464932,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"37","issue":"18","first_page":"2686","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-drug-reaction-reporting","display_name":"adverse drug reaction reporting","score":0.8579999804496765},{"id":"https://openalex.org/keywords/adverse-drug-reaction-monitoring","display_name":"adverse drug reaction monitoring","score":0.949999988079071},{"id":"https://openalex.org/keywords/traditional-chinese-medicine","display_name":"traditional Chinese medicine","score":0.8859999775886536},{"id":"https://openalex.org/keywords/regulatory-amendment","display_name":"regulatory amendment","score":0.656000018119812},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.7898591756820679},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6759931445121765},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.6166369318962097},{"id":"https://openalex.org/C188947578","wikidata":"https://www.wikidata.org/wiki/Q200253","display_name":"Traditional Chinese medicine","level":3,"score":0.6076147556304932},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5968965291976929},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.591041088104248},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4896243214607239},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.46251073479652405},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4252024292945862},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.32509398460388184},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10144859552383423}],"mesh":[{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004358","descriptor_name":"Drug Therapy","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D004365","descriptor_name":"Drugs, Chinese Herbal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004365","descriptor_name":"Drugs, Chinese Herbal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008516","descriptor_name":"Medicine, Chinese Traditional","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4268/cjcmm20121802","doi":"https://doi.org/10.4268/cjcmm20121802","is_oa":false,"landing_page_url":"https://doi.org/10.4268/cjcmm20121802","pdf_url":null,"source":{"id":"https://openalex.org/S2756327665","display_name":"China Journal of Chinese Materia Medica","issn_l":"1001-5302","issn":["1001-5302"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4320800687","host_organization_name":"Chinese Pharmaceutical Association","host_organization_lineage":["https://openalex.org/P4320800687"],"host_organization_lineage_names":["Chinese Pharmaceutical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"China Journal of Chinese Materia Medica","raw_type":"journal-article"},{"id":"pmid:23285908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23285908","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2037300759","https://openalex.org/W2377291378","https://openalex.org/W2379955664","https://openalex.org/W2390401718","https://openalex.org/W2380059967","https://openalex.org/W2378497431","https://openalex.org/W2352521373","https://openalex.org/W2351308524","https://openalex.org/W2385252149","https://openalex.org/W2375970852"],"abstract_inverted_index":{"The":[0],"newly":[1],"revised":[2,56],"Regulations":[3],"for":[4],"the":[5,22,37,44,55,62],"Administration":[6],"of":[7],"Adverse":[8],"Drug":[9],"Reaction":[10],"Reporting":[11],"and":[12,39,60],"monitoringhas":[13],"been":[14],"implemented":[15],"since":[16],"July":[17],"1,":[18],"2011.":[19],"It":[20],"is":[21],"most":[23],"important":[24],"regulation":[25,38],"on":[26,43],"adverse":[27,48],"drug":[28],"reaction":[29,49],"(ADR)":[30],"monitoring.":[31],"This":[32],"article":[33],"will":[34],"intensively":[35],"read":[36],"analysis":[40],"its":[41],"significance":[42],"traditional":[45],"Chinese":[46],"medicine":[47],"monitoring,":[50],"so":[51],"as":[52],"to":[53],"make":[54],"content":[57],"more":[58],"clear":[59],"guide":[61],"ADR":[63],"monitoring":[64],"working":[65],"better.":[66]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}